Acamprosate calcium as augmentation therapy for anxiety disorders

Annals of Pharmacotherapy

Volumn 44, Issue 12, 2010, Pages 1930-1932

  Schwartz, Thomas L ^a   Siddiqui, Umar A ^b   Raza, Shafi ^b   Costello, Anne ^b  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^b State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

Acamprosate; Augmentation; Generalized anxiety; Social anxiety

Indexed keywords

ACAMPROSATE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DREAMING; FEMALE; GASTROINTESTINAL SYMPTOM; GENERALIZED ANXIETY DISORDER; HUMAN; MALE; NAUSEA; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; REMISSION; SIDE EFFECT; SINGLE BLIND PROCEDURE; TREATMENT RESPONSE;

ADULT; ANTI-ANXIETY AGENTS; ANXIETY DISORDERS; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; TAURINE;

EID: 78649924498     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1P353     Document Type: Article

References (9)

1. Narrow WE, Rae DS, Robins LN, Regier DA. Revised prevalence estimates of mental disorders in the United States: using a clinical significance criterion to reconcile 2 surveys' estimates. Arch Gen Psychiatry 2002;59:115-23.
2. Ballenger JC. Current treatments of the anxiety disorders in adults. Biol Psychiatry 1999;46:1579-94.
3. Schwartz TL, Azhar N, Husain J, et al. An open-label study of tiagabine as augmentation therapy for anxiety. Ann Clin Psychiatry 2005;17:167-72.
4. A receptor function in health and disease. Biochem Soc Trans 2009;37:1317-22.
5. Cortese BM, Phan KL. The role of glutamate in anxiety and related disorders. CNS Spectr 2005;10:820-30.
6. Kranzler HR, Gage A. Acamprosate efficacy in alcohol-dependent patients: summary of results from three pivotal trials. Am J Addict 2008;17:70-6.
7. Scott LJ, Figgitt DP, Keam SJ, Waugh J. Acamprosate: a review of its use in the maintenance of abstinence in patients with alcohol dependence. CNS Drugs 2005;19:445-64.
8. Hertzman M, Patt IS, Spielman LA. Open-label trial of acamprosate as a treatment for Anxiety. Prim Care Companion J Clin Psychiatry 2009;11:267.
9. Product information. Campral (acamprosate calcium). St. Louis, MO: Forest Pharmaceuticals, August 2005.